Arq Bras Endocrinol Metab 2006;50(5):909-913

Follow-up of high-risk patients with differentiated thyroid cancer without persistent disease after initial therapy

Pedro Weslley S. do , Michelle A. Ribeiro , Maria Flávia Gatti , Saulo , Eduardo Lanza , Leonardo Lamego , Álvaro Luís

DOI: 10.1590/S0004-27302006000500012

This study evaluated the follow-up of high-risk patients with thyroid cancer after initial therapy. A total of 125 high-risk patients (tumor >4 cm and/or extrathyroid invasion and/or lymph node metastases, and age >45 years), with complete resection of the tumor, were selected. All patients underwent total thyroidectomy and ablation with 131I [3.7

Follow-up of high-risk patients with differentiated thyroid cancer without persistent disease after initial therapy

Comments (0)